| Literature DB >> 36039148 |
Ying Liu1, Zhifang Zhong1, Zhihong Li1, Xin Li2, Shengkun Zhang2, Jie Sun1, Jingfang Zhai3, Xuekui Liu4, Min Liu1.
Abstract
Aim: Exposure to famine in early life has been shown to increase the prevalence of non-alcoholic fatty liver disease (NAFLD). Neutrophil-to-lymphocyte ratio (NLR) is a risk factor for developing NAFLD. However, it is not clear that the association between NLR and NAFLD in individuals who were exposed to famine in early life.Entities:
Keywords: famine; neutrophil-to-lymphocyte ratio; non-alcoholic fatty liver disease; non-linear relationship
Year: 2022 PMID: 36039148 PMCID: PMC9419726 DOI: 10.2147/RMHP.S368369
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
The Clinical Characteristic of Participants According to Different Birth Period and Sex
| Variables | Birth in Famine Period | Birth in Normal Non-Famine Period | ||||
|---|---|---|---|---|---|---|
| Female | Male | Female | Male | Pa | Pb | |
| n | 2822 | 3303 | 1396 | 3026 | ||
| Age (years) | 52.31±1.22 | 52.30±1.24 | 52.38±1.47 | 52.28±1.51 | 0.125 | 0.561 |
| Weight (kg) | 61.01±8.41 | 74.48±9.58 | 61.71±8.14 | 74.09±9.68 | 0.01 | 0.109 |
| BMI(kg/m2) | 23.94±3.14 | 25.39±2.81 | 24.26±3.10 | 25.39±2.80 | 0.002 | 0.964 |
| SBP(mmHg) | 124.66±13.16 | 131.86±12.08 | 125.21±16.48 | 130.01±15.32 | 0.246 | <0.001 |
| DBP(mmHg) | 77.46±8.38 | 83.38±8.22 | 79.02±10.68 | 84.31±10.86 | <0.001 | <0.001 |
| FPG(mmol/L) | 5.50±1.17 | 5.99±1.74 | 5.44±1.25 | 6.03±1.74 | 0.114 | 0.441 |
| TC(mmol/L) | 5.29±0.89 | 4.97±0.89 | 5.27±0.99 | 5.06±0.95 | 0.443 | <0.001 |
| TG(mmol/L) | 1.59±0.98 | 1.94±1.46 | 1.45±1.18 | 1.94±1.73 | <0.001 | 0.942 |
| HDL(mmol/L) | 1.37±0.27 | 1.17±0.25 | 1.45±0.34 | 1.27±0.31 | <0.001 | <0.001 |
| LDL(mmol/L) | 3.32±0.72 | 3.18±0.70 | 3.25±0.85 | 3.12±0.78 | 0.006 | 0.002 |
| APO-A(g/L) | 1.39±0.23 | 1.28±0.21 | 1.41±0.27 | 1.29±0.27 | 0.31 | 0.525 |
| APO-B(g/L) | 0.91±0.21 | 0.93±0.21 | 0.99±0.26 | 1.01±0.25 | <0.001 | <0.001 |
| ALT(U/L) | 21.42±14.83 | 26.37±16.87 | 22.13±16.14 | 27.18±19.36 | 0.157 | 0.077 |
| AST(U/L) | 21.94±8.27 | 23.10±10.46 | 21.79±11.21 | 22.84±10.14 | 0.653 | 0.315 |
| TP(g/L) | 73.65±4.16 | 72.74±4.05 | 73.90±4.41 | 72.30±4.18 | 0.071 | <0.001 |
| ALB(g/L) | 45.16±2.34 | 45.98±2.27 | 45.76±2.06 | 46.27±2.06 | <0.001 | <0.001 |
| WBC(×109/L) | 5.29±1.26 | 6.03±1.46 | 5.47±1.39 | 6.27±1.52 | <0.001 | <0.001 |
| RBC(×1012/L) | 4.55±0.32 | 5.03±0.36 | 4.50±0.32 | 4.99±0.37 | <0.001 | <0.001 |
| HB(g/L) | 135.59±10.37 | 156.64±10.91 | 134.15±10.77 | 154.95±10.06 | <0.001 | <0.001 |
| PLT(×109/L) | 238.23±55.68 | 220.77±51.13 | 224.38±53.02 | 208.35±50.74 | <0.001 | <0.001 |
| LYC(×109/L) | 1.71±0.52 | 1.78±0.53 | 1.91±0.52 | 2.04±0.56 | <0.001 | <0.001 |
| NEUT(×109/L) | 3.18±1.03 | 3.75±1.20 | 3.13±1.11 | 3.66±1.17 | 0.175 | 0.006 |
| Smoking[n(%)] | 147 (5.21%) | 1038 (31.43%) | 89 (6.38%) | 967 (31.96%) | 0.121 | 0.651 |
| Hypertension[n(%)] | 639 (22.64%) | 1188 (36.4%) | 339 (24.28%) | 1151 (38.6%) | 0.235 | 0.065 |
| Diabetes[n(%)] | 97 (3.4%) | 296 (9.0%) | 39 (2.8%) | 296 (9.8%) | 0.265 | 0.263 |
Abbreviations: Pa, compared between females in different birthed period; Pb, compared between males in different birthed period; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein; APO-A, apolipoprotein A; APO-B, apolipoprotein B; ALT, glutamic-pyruvic transaminase; AST, glutamic-oxalacetic transaminase; TP, total protein; ALB, albumin; WBC, white blood cell; RBC, red blood cell; HB, hemoglobin; PLT, platelets; LYC, lymphocyte count; NEUT, neutrophil.
Figure 1The prevalence of non-alcoholic fatty liver disease (NAFLD) of two groups in different categories of neutrophil-to-lymphocyte ratio (NLR). Q1: NLR < 1.429%; Q2: NLR≥1.429%, NLR <1.860%; Q3: NLR≥1.860%, NLR<2.389%; Q4: NLR≥2.389%.
Figure 2The prevalence of non-alcoholic fatty liver disease (NAFLD) in different categories of neutrophil-to-lymphocyte ratio (NLR) and different gender. (A) The prevalence of NAFLD of two groups in different gender. (B) The prevalence of NAFLD of female participants in two groups in different categories of NLR. Q1: NLR < 1.429%; Q2: NLR≥1.429%, NLR <1.860%; Q3: NLR≥1.860%, NLR<2.389%; Q4: NLR≥2.389%. (C) The prevalence of NAFLD of male participants in two groups in different categories of NLR. Q1: NLR < 1.429%; Q2: NLR≥1.429%, NLR <1.860%; Q3: NLR≥1.860%, NLR<2.389%; Q4: NLR≥2.389%.
The Association Between NLR and NAFLD Using the Multi-Factor Regression Analysis
| Birth Period | NLR Levels | Beta | S.E | Wald | P | OR | 95% C.I | |
|---|---|---|---|---|---|---|---|---|
| Female | Famine period | Q1 | 1 | 1 | 1 | |||
| Q2 | 0.144 | 0.138 | 1.091 | 0.396 | 1.155 | 0.822~1.513 | ||
| Q3 | −0.049 | 0.135 | 0.134 | 0.714 | 0.952 | 0.730~1.240 | ||
| Q4 | 0.276 | 0.132 | 4.381 | 0.036 | 1.318 | 1.018~1.707 | ||
| Non-famine period | Q1 | 1 | 1 | 1 | ||||
| Q2 | 0.299 | 0.174 | 2.941 | 0.086 | 1.348 | 0.958~1.897 | ||
| Q3 | −0.01 | 0.186 | 0.003 | 0.957 | 0.991 | 0.688~1.424 | ||
| Q4 | 0.285 | 0.208 | 1.874 | 0.171 | 1.329 | 0.884~1.998 | ||
| Male | Famine period | Q1 | 1 | 1 | 1 | |||
| Q2 | 0.069 | 0.13 | 0.279 | 0.598 | 1.071 | 0.830~1.382 | ||
| Q3 | 0.128 | 0.123 | 1.084 | 0.298 | 1.137 | 0.893~1.446 | ||
| Q4 | 0.233 | 0.118 | 3.974 | 0.041 | 1.263 | 1.001~1.593 | ||
| Non-famine period | Q1 | 1 | 1 | 1 | ||||
| Q2 | −0.031 | 0.114 | 0.073 | 0.787 | 0.97 | 0.775~1.213 | ||
| Q3 | 0.08 | 0.122 | 0.434 | 0.51 | 1.084 | 0.853~1.377 | ||
| Q4 | −0.191 | 0.14 | 1.878 | 0.171 | 0.826 | 0.628~1.086 |
Notes: The model was adjusted age, BMI, blood lipid, FPG, WBC, RBC, smoking status, diabetes and hypertension.
Figure 3The association between NLR level and the risk of NAFLD under different gender in BF group. (A) The females; (B) the males.